Advertisement

Stryker Corp.'s Trevo medical device, designed to retrieve the blood clots that cause ischemic strokes.

Stryker Corp.

The FDA granted 510(k) clearance for Stryker's (NYSE:SYK) Trevo Pro blood clot retriever, technology it acquired along with Concentric Medical in 2011.

The medical device company said the stroke treatment device is the latest iteration of its Trevo line, designed to remove the blood clots that cause ischemic stroke.

The Trevo Pro uses the Stentretriever technology developed by Concentric, for which Stryker paid $135 million in the autumn of 2011.

Advertisement
Advertisement